Bizarre Patents
Self Containing Enclosure for Protection from Killer Bees
A self contained protective enclosure with an opening for entry and egress and a screen for ventilation and viewing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7265087 | Exendin improves β-cell response in subjects with impaired glucose tolerance A composition for the treatment of impaired glucose tolerance (IGT) including a compound which binds to a receptor for glucagon-like peptide-1, and a pharmaceutical carrier. The amount of the compound present is an effective amount to improve pancreatic β-cell sens... | 09/04/2007 |
| 6599914 | Inhibition of cytokine generation Methods of inhibiting the generation of pro-inflammatory cytokines such as IL-4 and IL-13 in a human patient in need of such inhibiting are disclosed.... | 07/29/2003 |
| 6410046 | Administering pharmaceuticals to the mammalian central nervous system A device, methods and pharmaceutical compositions are disclosed for transnasal or transocular drug delivery to the central nervous system using a combination of electrotransport or phonophoresis with chemical permeation enhancers.... | 06/25/2002 |
| 6369114 | Administration of an 댒-adrenergic receptor agonist to enhance cardiopulmonary resuscitation Methods, formulations and kits are described for resuscitating a patient suffering from cardiac arrest, for enhancing the efficacy of cardiopulmonary resuscitation, for treating post-resuscitation hypotension, and for reducing the incidence of ventricular... | 04/09/2002 |
| 6287597 | Antihistaminic/decongestant compositions Tannate compositions consisting essentially of pyrilamine tannate and phenylephrine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis and upper respirato... | 09/11/2001 |
| 6284257 | Cosmetic water emulsion containing at least one vegetable oil A cosmetic or dermatological composition in the form of a stable oil-in-water emulsion comprises (a) from 15 to 50 percent by weight of at least one vegetable oil containing at least 40 percent linoleic acid triglyceride, (b) from 2 to 7 percent by weight... | 09/04/2001 |
| 5895663 | Pseudoephedrine hydrochloride extended-release tablets Pseudoephedrine hydrochloride extended-release tablets including a sustained release hydroxypropylmethylcellulose matrix and a microcrystalline cellulose disintegrant formed by a dry mixed, direct compression method.... | 04/20/1999 |
| 5441938 | Factors which regulate macrophage antibacterial activity A novel therapy for Pseudomonas aeruginosa infections, in particular in cystic fibrosis patients, is described. Macrophages provide the first line of defence in protecting the lung against bacterial infections. Nonetheless, Pseudomonas aeruginosa infectio... | 08/15/1995 |
| 5409907 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 04/25/1995 |
| 5373010 | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives A method of treating a mammal comprises administering to a mammal an effective amount to provide a desired therapeutic effect in the mammal of a compound selected from the group consisting of those having the formula: ##STR1## , pharmaceutically acce... | 12/13/1994 |
| 5272137 | Aqueous pharmaceutical suspension for pharmaceutical actives The present invention relates to an aqueous pharmaceutical suspension composition comprising: from about 0.2% to 20% of a substantially water soluble pharmaceutical active, e.g. acetaminophen; a suspension stabilizing effective amount of xanthan gum and m... | 12/21/1993 |
| 5075340 | Retinoic acid glucuronide preparations for application to the skin A method and preparation are described for treating human skin with retinoic acid glucuronide (RAG) in a topical carrier. For treatment of acne or wrinkled skin, RAG can be applied in an effective amount which is nonirritating to the skin. Retinoid dermat... | 12/24/1991 |
| 4970240 | Fruity flavored nasal decongestant composition An aqueous, flavored, topical, nasal decongestant composition containing an amount of oxymetazoline or a pharmaceutically acceptable salt thereof, e.g., oxymetazoline HCl sufficient to effect nasal decongestion and an amount of a fruity flavor e.g. cherry... | 11/13/1990 |
| 4758424 | Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation A medicament adsorbate of decongestants and process for making same. The medicament adsorbate comprises a complex magnesium aluminum silicate having sorbed therein a decongestant. The complex magnesium aluminum silicate has the following typical chemical ... | 07/19/1988 |
| 4737519 | Substituted naphthalenes, indoles, benzofurans, and benzothiophenes as lipoxygenase inhibitors The present invention provides certain novel substituted naphthalenes, indoles, benzofurans, and benzothiophenes of Formula I which are useful as inhibitors of leukotriene biosynthesis and as inhibitors of lipoxygenase. They are thus employed wherever it ... | 04/12/1988 |
| 4632821 | Magnesium trisilicate suitable for preparation of medicament adsorbates of decongestants A medicament adsorbate containing a magnesium trisilicate having a surface area of at least 400 m2 /g and having a flake-like structure with multiple interstitial spaces, and having adsorbed therein from about 1% to about 20% by weight of the a... | 12/30/1986 |
| 4522759 | Polyprenylcarboxylic acid amides There is disclosed a polyprenylcarboxylic acid amide of the formula: ##STR1## wherein R1 represents a hydrogen atom or a lower alkyl group, R2 represents a hydrogen atom or a group of the formula: --COOR4 in which R | 06/11/1985 |
| 3933999 | Organic compounds The invention concerns novel combinations of active agents a) 1-methyl-2-[2-(-methyl-p-chlorodiphenylmethyloxy)ethyl]pyrrolidine and b) a non-toxic sympathicomimetic agent having a peripheral vasoconstrictive effect, useful in the treatment of rhin... | 01/20/1976 |
